The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Janis M Taube; Guray Akturk; Michael Angelo; Elizabeth L Engle; Sacha Gnjatic; Shirley Greenbaum; Noah F Greenwald; Cyrus V Hedvat; Travis J Hollmann; Jonathan Juco; Edwin R Parra; Marlon C Rebelatto; David L Rimm; Jaime Rodriguez-Canales; Kurt A Schalper; Edward C Stack; Cláudia S Ferreira; Konstanty Korski; Ana Lako; Scott J Rodig; Emanuel Schenck; Keith E Steele; Michael J Surace; Michael T Tetzlaff; Katharina von Loga; Ignacio I Wistuba; Carlo B Bifulco

doi:10.1136/jitc-2019-000155

Citation Tools

This article has a correction. Please see:

Correction: The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation - June 01, 2020

PDF

XML

Position article and guidelines

The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Taube JM, Akturk G, Angelo M on behalf of the Society for Immunotherapy of Cancer (SITC) Pathology Task Force., et al

The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Journal for ImmunoTherapy of Cancer 2020;8:e000155. doi: 10.1136/jitc-2019-000155

Log in using your username and password

Main menu

Log in using your username and password

You are here

This article has a correction. Please see:

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password